162 related articles for article (PubMed ID: 22244520)
21. The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study.
Klaasen R; Thurlings RM; Wijbrandts CA; van Kuijk AW; Baeten D; Gerlag DM; Tak PP
Arthritis Rheum; 2009 Nov; 60(11):3217-24. PubMed ID: 19877042
[TBL] [Abstract][Full Text] [Related]
22. Infliximab reduces CD147, MMP-3, and MMP-9 expression in peripheral blood monocytes in patients with active rheumatoid arthritis.
Huang J; Xie B; Li Q; Xie X; Zhu S; Wang M; Peng W; Gu J
Eur J Pharmacol; 2013 Jan; 698(1-3):429-34. PubMed ID: 23146660
[TBL] [Abstract][Full Text] [Related]
23. Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis.
Nissinen R; Leirisalo-Repo M; Peltomaa R; Palosuo T; Vaarala O
Ann Rheum Dis; 2004 Jun; 63(6):681-7. PubMed ID: 15140775
[TBL] [Abstract][Full Text] [Related]
24. Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Clin Exp Rheumatol; 2006; 24(5):529-33. PubMed ID: 17181921
[TBL] [Abstract][Full Text] [Related]
25. Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate.
Marchi LF; Paoliello-Paschoalato AB; Oliveira RDR; Azzolini AECS; Kabeya LM; Donadi EA; Lucisano-Valim YM
Rheumatol Int; 2018 Jun; 38(6):1043-1052. PubMed ID: 29464314
[TBL] [Abstract][Full Text] [Related]
26. Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy.
Wright HL; Thomas HB; Moots RJ; Edwards SW
Rheumatology (Oxford); 2015 Jan; 54(1):188-93. PubMed ID: 25125592
[TBL] [Abstract][Full Text] [Related]
27. Modification of neutrophil function by plasma of rheumatoid arthritis patients treated with infliximab.
Dain L; Braun-Moscovici Y; Baum E; Nahir AM; Hoffer E
Clin Exp Rheumatol; 2006; 24(1):38-44. PubMed ID: 16539817
[TBL] [Abstract][Full Text] [Related]
28. Increased tumor necrosis factor-alpha mRNA expression in whole blood from patients with rheumatoid arthritis: reduction after infliximab treatment does not predict response.
Pachot A; Arnaud B; Marrote H; Cazalis MA; Diasparra J; Gouraud A; Mougin B; Miossec P
J Rheumatol; 2007 Nov; 34(11):2158-61. PubMed ID: 17896807
[TBL] [Abstract][Full Text] [Related]
29. [Crucial role of TNFα-induced adipose-related protein (TIARP) in the pathogenesis of autoimmune arthritis].
Inoue A; Matsumoto I; Tanaka Y; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):51-5. PubMed ID: 22374443
[TBL] [Abstract][Full Text] [Related]
30. Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis.
Ingegnoli F; Fantini F; Griffini S; Soldi A; Meroni PL; Cugno M
Clin Exp Rheumatol; 2010; 28(2):254-7. PubMed ID: 20483049
[TBL] [Abstract][Full Text] [Related]
31. B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders.
La DT; Collins CE; Yang HT; Migone TS; Stohl W
Ann Rheum Dis; 2008 Aug; 67(8):1132-8. PubMed ID: 17967830
[TBL] [Abstract][Full Text] [Related]
32. Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis.
Peng T; Li B; Bi L; Zhang F
Biomed Pharmacother; 2024 May; 174():116551. PubMed ID: 38636399
[TBL] [Abstract][Full Text] [Related]
33. TNF-α-elicited miR-29b potentiates resistance to apoptosis in peripheral blood monocytes from patients with rheumatoid arthritis.
Ren B; Liu J; Wu K; Zhang J; Lv Y; Wang S; Liu L; Liu D
Apoptosis; 2019 Dec; 24(11-12):892-904. PubMed ID: 31473844
[TBL] [Abstract][Full Text] [Related]
34. Changes in chemokines and their receptors in blood during treatment with the TNF inhibitor infliximab in patients with rheumatoid arthritis.
Eriksson C; Rantapää-Dahlqvist S; Sundqvist KG
Scand J Rheumatol; 2013; 42(4):260-5. PubMed ID: 23379516
[TBL] [Abstract][Full Text] [Related]
35. DNA damage increase in peripheral neutrophils from patients with rheumatoid arthritis is associated with the disease activity and the presence of shared epitope.
Martelli-Palomino G; Paoliello-Paschoalato AB; Crispim JC; Rassi DM; Oliveira RD; Louzada P; Lucisano-Valim YM; Donadi EA
Clin Exp Rheumatol; 2017; 35(2):247-254. PubMed ID: 27908303
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritis.
van Baarsen LG; Wijbrandts CA; Gerlag DM; Rustenburg F; van der Pouw Kraan TC; Dijkmans BA; Tak PP; Verweij CL
Genes Immun; 2010 Dec; 11(8):622-9. PubMed ID: 20555356
[TBL] [Abstract][Full Text] [Related]
37. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
[TBL] [Abstract][Full Text] [Related]
38. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
[TBL] [Abstract][Full Text] [Related]
39. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
Gonzalez-Gay MA; Garcia-Unzueta MT; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
Clin Exp Rheumatol; 2006; 24(4):373-9. PubMed ID: 16956426
[TBL] [Abstract][Full Text] [Related]
40. Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway.
Korotkova M; Westman M; Gheorghe KR; af Klint E; Trollmo C; Ulfgren AK; Klareskog L; Jakobsson PJ
Arthritis Rheum; 2005 Nov; 52(11):3439-47. PubMed ID: 16255020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
